<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: GLENBROOK CAPITAL MANAGEMENT -->
          <cik>0001273782</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>11/13/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001680378</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>81720R604</issuerCusipNumber>
        </issuerCusips>
        <issuerName>SenesTech, Inc.</issuerName>
        <address>
          <com:street1>777 W. PINNACLE PEAK ROAD</com:street1>
          <com:street2>SUITE B104</com:street2>
          <com:city>PHOENIX</com:city>
          <com:stateOrCountry>AZ</com:stateOrCountry>
          <com:zipCode>85027</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Ruba Qashu</personName>
          <personPhoneNum>858-397-7428</personPhoneNum>
          <personAddress>
            <com:street1>Dickinson Wright PLLC</com:street1>
            <com:street2>3579 Valley Centre Drive, Suite 100</com:street2>
            <com:city>San Diego</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>92130</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001273782</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>GLENBROOK CAPITAL MANAGEMENT</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>NV</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2196973.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2196973.00</sharedDispositivePower>
        <aggregateAmountOwned>2196973.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>32.2</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>Comment for Row 13: Based on 6,823,881 shares of Common Stock outstanding as of November 12, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 13, 2026.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>SenesTech, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>777 W. PINNACLE PEAK ROAD</com:street1>
          <com:street2>SUITE B104</com:street2>
          <com:city>PHOENIX</com:city>
          <com:stateOrCountry>AZ</com:stateOrCountry>
          <com:zipCode>85027</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 4 ("Amendment No. 4") amends the statement on Schedule 13D filed by the Reporting Person on July 23, 2026, as amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3 (as amended, the "Schedule 13D"), with respect to the Common Stock, par value $0.001 per share (the "Common Stock"), of SenesTech, Inc. (the "Issuer"). This Amendment No. 4 amends Items 4 and 5 as set forth below. Capitalized terms used but not defined in this Amendment No. 4 have the meanings given in the Schedule 13D.</commentText>
      </item1>
      <item4>
        <transactionPurpose>Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following:

Since the filing of Amendment No. 3, the Reporting Person has communicated with members of the Issuer's Board of Directors and management regarding the following matters:

Costs. The Reporting Person believes that the Issuer's operations reflect inefficiencies and excessive costs. It has recommended that the Issuer immediately wind down certain consulting and marketing roles, halt certain bonus accruals and have Sandstrom Partners, Inc. ("Sandstrom"), which the Issuer engaged as a strategic advisor in October 2026, oversee the Issuer's marketing strategy. As previously disclosed, the Reporting Person holds a minority ownership interest in Sandstrom.

Consulting agreements. The Reporting Person has requested copies of the consulting agreements the Issuer has entered into since October 2025, expressing a preference to obtain them cooperatively rather than through a formal demand under Section 220 of the Delaware General Corporation Law. The Reporting Person understands that the Issuer is assembling those agreements.

Dilution. The Issuer has disclosed that on October 20, 2026 it received notice from Nasdaq that the Common Stock did not satisfy the $1.00 minimum bid price requirement. The Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026 reflects that, after the end of that quarter, the Issuer sold approximately 1.3 million shares of Common Stock under its at-the-market offering program, increasing the number of shares outstanding by approximately 25%. The Issuer has stated that those sales were made at an average price of approximately $0.92 per share. The Reporting Person has expressed its serious concern regarding those sales in communications with members of the Board. The Reporting Person believes that those sales were ill-advised and irresponsible and that they have weighed on the market price of the Common Stock.

Disclosure and governance. The Reporting Person has informally raised questions with members of the Board regarding the completeness and timeliness of the Issuer's public disclosures relating to a prior business of the Issuer's Chief Executive Officer. The Reporting Person has also objected to a consulting arrangement between the Issuer and a current director and has stated to members of the Board its view that the director is not independent, notwithstanding the Issuer's determination that the director is independent.

Board composition. The Reporting Person previously introduced JoAnna Abrams to the Issuer and supports her appointment to the Board, effective November 16, 2026, as announced by the Issuer on November 17, 2026. The Reporting Person holds approximately 5% of the outstanding equity of Mindclick, of which Ms. Abrams is the founder and chief executive officer, and a convertible note issued by Mindclick. The Reporting Person's most recent equity investment in Mindclick was made in October 2026. The Reporting Person has no agreement, arrangement or understanding with Ms. Abrams regarding her service on the Issuer's Board or the acquisition, holding, voting or disposition of the Issuer's securities, and has no right to designate a director of the Issuer.

Director compensation. The Issuer's 2026 proxy statement reports that the annual cash retainer for non-employee directors increased from $27,000 to $40,000 after July 2025 and that committee retainers also increased. As stated in the letter filed as Exhibit 99.1 to Amendment No. 1, the Reporting Person has urged the Board to consider equity awards in place of a portion of cash compensation.

The Reporting Person intends to continue its discussions with the Board and management regarding these matters. It may request to inspect books and records of the Issuer under Section 220 of the Delaware General Corporation Law and may ask the Board to review its director independence determinations. The Reporting Person has not determined whether to nominate director candidates, solicit proxies or submit a stockholder proposal. The Reporting Person may change its plans at any time and may acquire or dispose of securities of the Issuer.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>See rows (11) and (13) of the cover page to this Schedule 13D for the aggregate number of shares of Common Stock and the percentage of the Common Stock beneficially owned by the Reporting Person. The percentage is based on 6,823,881 shares of Common Stock outstanding as of November 12, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 13, 2026. The decrease in the percentage reported since Amendment No. 3 results solely from an increase in the number of shares of Common Stock outstanding. Because the Issuer may continue to sell Common Stock under its at-the-market offering program, the number of shares currently outstanding may be higher, and the Reporting Person's percentage ownership lower, than reported here.</percentageOfClassSecurities>
        <numberOfShares>See rows (7) through (10) of the cover page to this Schedule 13D for the number of shares of Common Stock as to which the Reporting Person has sole or shared power to vote or direct the vote and sole or shared power to dispose or direct the disposition.</numberOfShares>
        <transactionDesc>The Reporting Person has not effected any transactions in the Common Stock since the filing of Amendment No. 3.</transactionDesc>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>GLENBROOK CAPITAL MANAGEMENT</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Robert W. Lishman</signature>
          <title>Robert W. Lishman/Director</title>
          <date>11/17/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
